Search bioRxiv⌕ Search

Biology subjects

Niu, M.

Publications and source records attributed to Niu, M..

At least 19 recordsLinked to original sources

Biologically grounded cell profiling across microscopy modalities

Microscopy-based cell profiling has broad applications in biological discovery, disease characterization, and phenotypic drug screening. Modern microscopy continues to push the limits of resolution, speed, depth and throughput, but better imaging does not automatically lead to better biomedical discovery and translation. A key bottleneck is feature representation: existing features are either handcrafted or learned as black-box embeddings and often lack explicit biological meaning. Here we propose biological grounding as a first principle for cell profiling and implement it through MorphAgent, an AI agent framework in which each quantitative feature originates from a biological hypothesis and is anchored to a cellular structure or process. By integrating biological knowledge, multimodal reasoning and automated validation, MorphAgent makes biologically grounded feature design systematic and scalable. We show biological grounding fundamentally changes the properties of cell profiling features. Across three microscopy modalities, MorphAgent produces compact, expressive and transferable features for drug screening, cell state characterization and disease morphology analysis. In wide-field Cell Painting, a common assay for phenotypic drug screening, it improves perturbation-retrieval mean average precision by 48% over CellProfiler and 20% over DeepProfiler while using substantially fewer dimensions. In confocal mitochondrial imaging, biologically grounded features transfer across independently acquired datasets and imaging resolutions, supporting accurate aging-state classification. In structured illumination microscopy (SIM) imaging of Tau-labeled samples, biologically grounded super resolution features reveal nanoscale morphologies inaccessible at conventional resolution, enhancing the discrimination of disease-associated mutations. Moreover, biologically grounded features provide a hierarchical organization of cellular morphology, enabling multilevel alignment with transcriptomics data and facilitating mechanistic understanding. Biologically grounded cell profiling thus brings AI reasoning closer to biological mechanisms, advancing biomedical discovery and translation.

bioinformatics↗

Minipoa: A minimizer-based method for fast and memory-efficient partial order alignment

Partial order alignment (POA) has emerged as a fundamental component in long-read error correction, assembly and pangenomics. However, conventional POA algorithms are limited by high time and memory requirements, making them inefficient for large-scale datasets. Here, we present minipoa, a fast and memory-efficient POA tool that incorporates seed-chain-align heuristics, adaptive or static banding strategies, and single-instruction multiple-data optimizations. Minipoa achieves up to a 5-fold speedup over abPOA, reduces memory usage by up to 16-fold, and improves correction accuracy, while maintaining strong performance on both PacBio and ONT simulated datasets, and can be readily integrated into existing long-read error correction and assembly workflows. In multiple sequence alignment datasets, minipoa demonstrates superior computational efficiency and alignment accuracy compared with all other tested tools, achieving Total Column scores up to 2.5-fold higher than MAFFT in low-similarity scenarios. Moreover, minipoa enables multiple sequence alignment of megabase-long genomes and million-sequence datasets, demonstrated by 342 Mycobacterium tuberculosis sequences and one million SARS-CoV-2 sequences respectively. Collectively, minipoa is well positioned to become a cornerstone in the era of large-scale pangenomics.

bioinformatics↗

Single Plaque Proteomics Reveals the Composition and Dynamics of the Amyloid Microenvironment in Alzheimer's Disease

Alzheimers disease (AD) is characterized by amyloid plaques that form complex microenvironments in the brain. However, the molecular composition of these plaques and their temporal regulation are not well defined. Here, we developed a sensitive workflow for quantitative proteomic profiling of single plaques using refined laser capture microdissection and data-independent acquisition mass spectrometry (LCM-DIA-MS). From >200 plaques and control regions in AD mouse models (5xFAD and APP-KI) and human brains, we quantified >7,000 proteins, revealing stage-dependent, cell-type-related remodeling of the amyloid proteome (amyloidome). Temporal profiling uncovered early immune and lysosomal activation followed by engagement of RNA processing and synaptic pathways. Cross-model and cross-species analyses determined a conserved amyloidome including APOE, MDK, PTN, and HTRA1, validated by co-localization in imaging analysis. Network analysis highlighted modules in lipid transport, vesicle organization, and autophagy. These findings establish amyloid plaques as conserved, dynamic multicellular hubs that link amyloid accumulation to downstream cellular events.

neuroscience↗

Longitudinal Proteomics Analysis of Cerebrospinal Fluid in Survivors of Childhood Acute Lymphoblastic Leukemia

Mass spectrometry-based proteomic profiling of cerebrospinal fluid (CSF) in large patient cohorts, particularly among childhood cancer survivors, remains scarce, limiting opportunities for benchmarking, method development, and validation. Here, we present a longitudinal CSF proteomics dataset from survivors of childhood acute lymphoblastic leukemia (ALL). Samples were collected from 178 patients enrolled in the TOTXVI therapeutic protocol at two timepoints: diagnosis (pre-treatment) and during the consolidation phase of chemotherapy (totaling 356 samples). CSF proteomes were profiled using tandem-mass-tag (TMT) labeling coupled with extensive fractionation and high-resolution liquid chromatography-tandem mass spectrometry (LC/LC-MS/MS). The dataset includes quantitative profiles for more than 3,000 confidently identified unique proteins. This resource enables the investigation of chemotherapy-induced alterations in the CSF proteome and provides a valuable resource for studying the molecular mechanisms of neurotoxicity, identifying biomarkers of adverse late effects, and guiding the development of neuroprotective strategies in childhood cancer survivors.

systems biology↗

SigFormer: an Attention-Based Framework for Robust Single-Sample Mutational Signature Decomposition

Somatic mutational signatures imprint the history of exogenous exposures and endogenous processes on the genome, offering critical insights into pathologic etiology and disease risk. However, accurate signature decomposition at the single-sample level is still challenging when mutation burden is low, sampling noise is high, and candidate catalogs are large and redundant. Here, we present SigFormer, a set-conditioned transformer framework designed to facilitate robust somatic mutation analysis without reliance on large cohorts. By leveraging a cross-attention mechanism between customized reference input and sample mutation profile, SigFormer improves exposure recovery and detection accuracy compared with likelihood-driven refitting (MuSiCal) with the largest performance gains in high-noise and overcomplete settings. On PCAWG genomes, SigFormer preserves major tissue-level structure while sensitively and accurately capturing cooccurrence of low-abundance signatures but without the need for tumor-type-specific gating. In low-burden normal-tissue datasets spanning clonal expansion and microdissection studies, SigFormer maintains the high accuracy and recovers stable tissue-dependent patterns of SBS1/SBS5/SBS40a, pointing to underlying tissue-specific mutagenic heterogeneity in normal tissues. Finally, SigFormer quantifies an explicit unattributable residual component when the catalogue is incomplete, preventing forced allocation into flexible flat signatures and providing a useful signal for downstream analyses.

bioinformatics↗

Benchmarking of duplex sequencing approaches to reveal somatic mutation landscapes

Detecting somatic mutations in normal tissues is challenging due to sequencing errors and the low allele fractions of post-zygotic variants. Duplex sequencing greatly reduces errors and can detect mutations at any allele fraction, but systematic, cross-platform comparisons are lacking. We present a comprehensive benchmarking of six duplex sequencing technologies used by the SMaHT Network: CODEC, CompDuplex-seq, HiDEF-seq, NanoSeq, ppmSeq, and VISTA-seq. We evaluated their performance using cord blood DNA, a tumor-normal cell line mixture, and homogenates from six human tissues. Each method shows distinct profiles in genomic footprint, sensitivity, and cost. Despite differences in library construction and sequencing platforms, estimates of mutation rates and mutational signatures are highly concordant. Integration with ultra-deep whole-genome sequencing shows that duplex approaches sensitively capture mutations and signatures beyond embryonic or clonally expanded variants. These results provide a foundation for selecting duplex methods and interpreting their data, enabling scalable single-molecule analyses of somatic mutation landscapes. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=101 SRC="FIGDIR/small/692823v1_ufig1.gif" ALT="Figure 1"> View larger version (46K): org.highwire.dtl.DTLVardef@123b221org.highwire.dtl.DTLVardef@83ba0aorg.highwire.dtl.DTLVardef@2b0ab0org.highwire.dtl.DTLVardef@1cae35e_HPS_FORMAT_FIGEXP M_FIG C_FIG

genomics↗

Expanding the Genome in a Bottle Truth Set: Detection and Validation of Novel Low-frequency Variants Using High-accuracy NanoSeq

HighlightsO_LINanoSeq-MBN achieves near-genome, Poisson-like coverage with minimal trinucleotide bias. C_LIO_LIExpands the GIAB truth set by up to 160k de novo variants. C_LIO_LIAdds a somatic layer to GIAB, enabling benchmarking and calibration of rare variants. C_LIO_LIHigh-CADD exonic and splice variants highlight value for surveillance and clinical triage. C_LI Somatic mutations record tissue molecular history and inform risk, prognosis, and therapy, yet their variant allele fractions often fall below the reliable detection limit of conventional short-read sequencing. In contrast, duplex sequencing technology featured by NanoSeq applies the principle of single molecule detection and thereby overcomes the limitation. However, the original NanoSeq protocol relies on the restriction enzyme-based genome fragmentation, which constrained its genome coverage to 30-40%. To enable whole-genome discovery with duplex-level fidelity, we pursued two complementary approaches to optimize the NanoSeq protocol: (i) a restriction-enzyme strategy densifies accessible sites using orthogonal 4-bp cutters; and (ii) a workflow using sonication followed by mung bean nuclease with T4 polynucleotide kinase, Klenow fragment and dATP/ddBTP mixture (NanoSeq-MBN) to blunt and repair/A-tailing DNA, while minimizing repair artifacts. We systematically benchmarked their performance using Genome in a Bottle (GIAB) gold-standard sample mixtures. As a result, NanoSeq-MBN achieved near genome-wide, Poissonlike coverage with minimal trinucleotide-context bias and ultra-high accuracy. Beyond variants already present in the GIAB truth set, NanoSeq-MBN identified approximately 120,000-160,000 de novo mutations per sample missing in the truth set, Notably, over 98% had orthogonal support in reanalyzed GIAB bulk Illumina HiSeq libraries. These novel variants extended GIAB from germline benchmarking to rare-variant discovery and calibration of subclonal detection. Functional annotation revealed enrichment of high Combined Annotation Dependent Depletion (CADD) scores mutations in exonic and splice-related regions. Variants intersecting ClinVar entries and OMIM genes highlighted potential for surveillance and clinical triage. Collectively, these results add a somatic layer to GIAB, enabling calibration of burdens and mutational signatures in lymphoblastoid lines and provide reference material for rare-variant assays. The NanoSeq-MBN workflow offers a path to whole-genome, high-fidelity discovery of ultra-rare somatic variation with relevance to clinical assay validation.

molecular biology↗

Timing the onset of homologous recombination deficiency before cancer diagnosis

Mutations in BRCA1 and BRCA2 genes, whether inherited or somatically acquired, cause homologous recombination deficiency (HRD) in tumor cells. The timing of HRD onset in the emerging tumor lineage is unknown. Here, we present HRDTimer, an algorithm to infer the onset of HRD-driven mutagenesis prior to cancer diagnosis. We estimate that HRD arises at 34% of SBS1-based molecular time---corresponding to a median of 8.3 years (IQR 7.1--10.4) prior to diagnosis in triple-negative breast cancers, and 15.0 years (IQR 12.0--20.6) in ER-positive breast cancers. Bulk sequencing reveals accelerated SBS1 accumulation following neoplastic transformation compared to normal tissue, influencing the estimated age of HRD onset. Single-cell duplex sequencing confirms SBS1 acceleration in tumors and further shows that non-tumor cells largely lack the HRD signature, indicating that HRD is rare in pre-malignant cells, even in BRCA1/2 mutation carriers. Together, our analysis pinpoints the onset of HRD before diagnosis, defining a window for detection and potential interception.

genomics↗

Cocaine Acts Through Sigma-1 to Enhance HIV Infection of Microglia

Cocaine use disorder is highly comorbid in people with HIV and can accelerate infection, alter neuropathology, and exacerbate cognitive decline despite antiretroviral therapy (ART). Many of these effects are due to infection and dysregulation of CNS myeloid cells, especially microglia, which comprise a significant reservoir in this compartment. However, the precise mechanism(s) by which cocaine (Coc) enhances HIV infection in microglia are unclear, partly due to the lack of translationally relevant human microglial models suitable for mechanistic evaluation of Coc-mediated changes in viral dynamics. Canonically, Coc acts by blocking dopamine transporter activity, however, Coc has additional mechanisms beyond dopaminergic tone, involving the endoplasmic reticulum (ER) protein sigma-1, which has diverse cellular functions, including modulation of stress pathways such as the unfolded protein response (UPR). Viruses, including HIV, can exploit the UPR to amplify stress-induced protein production in host cells, enhancing viral replication. Therefore, we hypothesized that Coc-mediated activation of sigma-1 increases HIV infection of microglia via activation of the UPR. Using human-induced pluripotent stem cell microglia (iPSC-Mg), we evaluated changes in the percentage of infected iMg as well as p24Gag secretion using high-content imaging and AlphaLISA. Coc increased both p24 secretion and the number of infected iMg. The enhanced p24 secretion persisted despite ART, without the corresponding increase in percent p24, suggesting Coc augments the post-entry steps of viral replication. Inhibition of dopamine receptors did not diminish the impact of Coc, but pharmacological inhibition and CRISPR KO of sigma-1 blocked the effect. Independently, sigma-1 agonists increased p24 secretion, suggesting that Coc acts through sigma-1 rather than dopaminergic pathways. Single-cell RNA sequencing revealed distinct transcriptomic alterations in HIV+Coc-treated iPSC-Mg. Further genetic and proteomic validation confirmed activation of the IRE1-XBP1 branch of the UPR in the HIV+Coc condition, with increased XBP1 signaling and downstream cytokine (IL-4 and IL-7) secretion. The HIV+Coc condition also showed reduced expression of antiviral response genes and enhanced HIV transcriptional regulation genes. Immunofluorescence staining showed increased sigma-1 in p24-cells and reduced sigma-1 in p24+ cells in HIV+Coc cultures and revealed that HIV+Coc promotes sigma-1 movement to the ER. These findings suggest that Coc exploits sigma-1 signaling to modulate the UPR, enhancing viral replication and immune evasion. Sigma-1 emerges as a critical link between HIV-induced cellular stress and cocaine exposure, highlighting a shared molecular pathway that can be leveraged for the treatment of comorbid HIV neuropathogenesis, substance use disorder, and related neuropsychiatric disorders.

immunology↗

CAT-APP: Contamination Analysis and Tempering--An Automated Online Platform for Plasma Proteomics with Data Rescuing Capabilities

Plasma and serum proteome profiling have become central to biomarker discovery for medical research. The advent of high-throughput plasma proteomics pipelines has enabled the generation of massive datasets. However, biomarker discovery is frequently compromised by sample contamination, primarily from erythrocytes, platelets, and coagulation factors. Such contamination can lead to the false identification of contaminants as biomarkers in over 50% of studies or obscure genuine biomarkers due to contamination-induced variability. Currently, no tools are available to salvage such compromised data, and the default approach is often to discard the affected samples. To address this gap, we introduce CAT-APP (Contamination Analysis and Tempering-An Automated Online Platform for Plasma Proteomics). CAT-APP tackles contamination through three key modules: multi-dimensional contamination assessment and adaptive contamination indexing, mathematical model-based contamination tempering, and data recovery evaluation with visualization. We applied CAT-APP to 28 independent plasma proteomics datasets and found that 82% exhibited contamination issues. CAT-APP markedly improved data quality by removing false-positive biomarkers introduced by contamination and restoring true biological signals that were previously obscured in representative datasets. To promote widespread adoption, we provide CAT-APP as an freely accessible, user-friendly, and robust web platform at https://www.bloodecosystem.com/tools/CAT-APP/.

bioinformatics↗

Three cortical streams for somatosensory information processing

AbstractThe somatosensory cortex processes information hierarchically, transforming sensory input into appropriate responses. This hierarchy, in turn, provides a fundamental principle for the organization of anatomical and functional properties across the somatosensory cortex. While the local somatosensory hierarchy has been studied, a comprehensive model that fully illustrates somatosensory information transmission in fine detail remains lacking. In this study, we examine multimodal connectivity patterns of the entire macaque somatosensory cortex by integrating the information from receptor covariance (RC) and structural (SC) or functional connectivity (FC). Our findings not only reveal the hierarchical relationships but also propose a model of somatosensory processing streams. In this model, area 3bl serves as the initial cortical stage for somatosensory signals, projecting to areas 3al, 1, and 2. From there, somatosensory signals follow three major pathways: ventrally to the SII complex, medially to the medial SI and TSA, and posteriorly to somatosensory association areas in the parietal lobe. Further analysis shows that RC is not only closely linked to SC and FC but in addition displays unique characteristics that likely relate to the hierarchical processing across sensory modalities. This study deepens our understanding of brain connectivity patterns across different modalities and links the structural, chemoarchitectonic, and functional organization of the macaque somatosensory cortex.

neuroscience↗

Studying cis-regulatory heterogeneity in single-cells at allelic resolution

Single-cell RNA-seq data from F1 hybrids provides a unique framework for dissecting complex regulatory phenomena, but allelic measurements are limited by technical noise. Here, we present ASPEN, a statistical method for modeling allelic mean and variance in single-cell transcriptomic data from F1 hybrids. ASPEN uses a sensitive mapping pipeline and adaptive shrinkage to distinguish allelic imbalance and variance in single cells. Through extensive simulation based on sparse droplet-based single-cell data, ASPEN demonstrates improved sensitivity and control of false discoveries compared to existing approaches. Applied to mouse brain organoids and T cells, ASPEN identifies genes with incomplete X inactivation, stochastic monoallelic expression, and significant deviations in allelic variance. This reveals reduced variance in essential cellular pathways, and increased variance in neurodevelopmental and immune-specific genes.

bioinformatics↗

Novel Probe Design for Multi-Gene Detection Enabled by Cleavage and Capillary Electrophoresis

Nucleic acid sequences carry the most fundamental information about life, and gene detection plays a crucial role in studying and applying gene function. Here, we present a novel probe design that utilizes probe cleavage and capillary electrophoresis for gene detection, termed ProbeCE which detects genes by measuring the relative fluorescence signal intensity. Through the evaluation of probes with varying lengths and modifications, ProbeCE is believed to support the simultaneous detection of hundreds of genes. Additionally, the assessment of low-concentration samples has demonstrated the high sensitivity of the ProbeCE method. Compared to the conventional amplification product capillary electrophoresis (AmpCE) method, this new approach significantly increases detection throughput while simplifying primer design and enhancing specificity. In addition, ProbeCE is less expensive than current medium- or high-throughput sequencing for detecting large numbers of known genes. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=85 SRC="FIGDIR/small/643483v1_ufig1.gif" ALT="Figure 1"> View larger version (19K): org.highwire.dtl.DTLVardef@188decborg.highwire.dtl.DTLVardef@dae443org.highwire.dtl.DTLVardef@c01a55org.highwire.dtl.DTLVardef@d653_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗

Regulatory T and activated T cells in the chronic unpredictable mild stress mice: sex differences and effects of treatments

Background: Major depressive disorder (MDD) is associated with immune dysregulation, including T-cell activation and reduced regulatory T cells. Pharmacological treatments like fluoxetine, simvastatin, curcumin, and S-adenosylmethionine (SAMe) show promise in alleviating depressive symptoms, but their effects on immune responses are not fully understood. Methods: This study explored immune status in MDD using the chronic unpredictable mild stress (CUMS) mouse model. It examined how fluoxetine, simvastatin, curcumin, and SAMe affected immune responses and depressive behaviors. The study also investigated sex differences. Six groups, each with 12 mice (6 males and 6 females), were included: control, CUMS, and drug treatments. Male and female mice were housed separately in sex-specific cages throughout the experiment, with three mice per cage. Behavioral tests included sucrose preference, forced swimming, open field, and active avoidance. Immune cell markers were analyzed by flow cytometry. Results: CUMS mice showed immune imbalance, with Treg depletion (p = 0.047) and a higher CD154/CD152 ratio (p = 0.006). All treatments improved depressive-like behaviors (all p < 0.05), with SAMe normalizing the CD154/CD152 ratio (p = 0.009). Furthermore, female mice exhibited lower levels of Treg-related immune regulation and T-cell activation compared to males (both p < 0.001), along with a higher CD154/CD152 ratio (p = 0.008). Conclusion: This study highlights that curcumin, simvastatin, fluoxetine, and SAMe alleviate depressive-like behaviors, while SAMe also reduces the CD154/CD152 ratio. These findings reveal marked sex differences in T-cell activation and immune regulation, highlighting the importance of considering sex as a biological variable in CUMS research.

immunology↗

Divergent effects of 3-nitrooxypropanol on enteric methane emissions in Holstein and Brown Swiss cows, and its lack of synergy with Acacia mearnsii tannin extract

The objectives of this study were to investigate the combined effects of 3-nitrooxypropanol (3-NOP) and Acacia mearnsii tannin extract (TAN), and their interactions with dairy cattle breed [Brown Swiss (BS) vs. Holstein Friesian (HF)], on lactational performance, and enteric methane (CH4) emissions. Sixteen multiparous mid-lactation cows, including 8 BS and 8 HF cows were used in a split-plot design, with breed as the main plot. Cows within each subplot were arranged in a replicated 4 x 4 Latin Square design with a 2 x 2 factorial arrangement of treatments across four 24-d periods. The experimental diets were: 1) CON (basal total mixed ration), 2) 3-NOP (60 mg/kg DM), 3) TAN (3% of DM), and 4) 3-NOP + TAN. Spot samples of urine, feces, and gas emissions (via GreenFeed) were collected at the end of each period 8 times over 3 days. No 3-NOP x TAN x Breed interactions were observed for DM intake (DMI), milk production, or enteric gas emissions, except for CH4 yield (g/kg DMI) and CO2 production. Breed influenced DMI, milk production, and component yields, with HF cows consuming 3.7 kg/d more DMI, producing 9.3 kg/d more milk, and achieving greater feed efficiency and higher milk component yields than BS cows. Milk yield and energy-corrected milk (ECM) tended to increase in HF but tended to decrease in BS cows by 3-NOP. Cows fed TAN had 1 kg/d lower DMI with the tendency for 3-NOP x TAN showed greater reduction when TAN was fed alone, but milk yield, ECM, and feed efficiency remained unchanged. Cows fed TAN exhibited 18% lower milk urea nitrogen (N) concentration and 23.0% lower urinary N but 36.7% greater fecal N excretions as a percentage of daily N intake. A 3-NOP x Breed interaction was observed in CH4 production (g/d), with a 21.7% reduction in HF, and a 13.0% reduction in BS. Similarly, there were 3-NOP x Breed tendencies in CH4 yield and intensity (g/kg ECM), with reductions in HF cows of 21.8% and 23.4%, respectively, compared to 11.0% and 10.8% in BS cows. In conclusion, there were no synergistic or additive effects between 3-NOP and TAN on enteric CH4 mitigation. The enteric CH4 emission mitigating effect of 3-NOP was more pronounced in HF cows than in BS cows. Further research is needed to understand breed-specific responses and to optimize CH4 mitigation strategies for inclusion in national greenhouse gas inventories. ImplicationsThis study demonstrated that the feed additive 3-nitrooxypropanol reduces enteric methane emissions in dairy cows, with a greater reduction observed in Holsteins (22%) compared to Brown Swiss (13%) cows. While combining 3-NOP with Acacia mearnsii tannin extract did not further reduce methane. Feeding Acacia mearnsii extract decreased nitrogen excretion, potentially reducing environmental nitrogen pollution from manure. Neither additive substantially impacted milk production; however, 3-nitrooxypropanol tended to increase milk yield in Holsteins while reducing it in Brown Swiss. Overall, this study suggests that enteric methane mitigation efficacy of dietary strategies for different cattle breeds should be further investigated.

animal behavior and cognition↗

Human-mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidome

Murine models of Alzheimers disease (AD) are crucial for elucidating disease mechanisms but have limitations in fully representing AD molecular complexities. We comprehensively profiled age-dependent brain proteome and phosphoproteome (n > 10,000 for both) across multiple mouse models of amyloidosis. We identified shared pathways by integrating with human metadata, and prioritized novel components by multi-omics analysis. Collectively, two commonly used models (5xFAD and APP-KI) replicate 30% of the human protein alterations; additional genetic incorporation of tau and splicing pathologies increases this similarity to 42%. We dissected the proteome-transcriptome inconsistency in AD and 5xFAD mouse brains, revealing that inconsistent proteins are enriched within amyloid plaque microenvironment (amyloidome). Determining the 5xFAD proteome turnover demonstrates that amyloid formation delays the degradation of amyloidome components, including A{beta}-binding proteins and autophagy/lysosomal proteins. Our proteomic strategy defines shared AD pathways, identify potential new targets, and underscores that protein turnover contributes to proteome-transcriptome discrepancies during AD progression.

biochemistry↗

Dopamine-driven Increase in IL-1β in Myeloid Cells is Mediated by Differential Dopamine Receptor Expression and Exacerbated by HIV

The catecholamine neurotransmitter dopamine is classically known for regulation of central nervous system (CNS) functions such as reward, movement, and cognition. Increasing evidence also indicates that dopamine regulates critical functions in peripheral organs and is an important immunoregulatory factor. We have previously shown that dopamine increases NF-{kappa}B activity, inflammasome activation, and the production of inflammatory cytokines such as IL-1{beta} in human macrophages. As myeloid lineage cells are central to the initiation and resolution of acute inflammatory responses, dopamine-mediated dysregulation of these functions could both impair the innate immune response and exacerbate chronic inflammation. However, the exact pathways by which dopamine drives myeloid inflammation are not well defined, and studies in both rodent and human systems indicate that dopamine can impact the production of inflammatory mediators through both D1-like dopamine receptors (DRD1, DRD5) and D2-like dopamine receptors (DRD2, DRD3, and DRD4). Therefore, we hypothesized that dopamine-mediated production of IL-1{beta} in myeloid cells is regulated by the ratio of different dopamine receptors that are activated. Our data in primary human monocyte-derived macrophages (hMDM) indicate that DRD1 expression is necessary for dopamine-mediated increases in IL-1{beta}, and that changes in the expression of DRD2 and other dopamine receptors can alter the magnitude of the dopamine-mediated increase in IL-1{beta}. Mature hMDM have a high D1-like to D2-like receptor ratio, which is different relative to monocytes and peripheral blood mononuclear cells (PBMCs). We further confirm in human microglia cell lines that a high ratio of D1-like to D2-like receptors promotes dopamine-induced increases in IL-1{beta} gene and protein expression using pharmacological inhibition or overexpression of dopamine receptors. RNA-sequencing of dopamine-treated microglia shows that genes encoding functions in IL-1{beta} signaling pathways, microglia activation, and neurotransmission increased with dopamine treatment. Finally, using HIV as an example of a chronic inflammatory disease that is substantively worsened by comorbid substance use disorders (SUDs) that impact dopaminergic signaling, we show increased effects of dopamine on inflammasome activation and IL-1{beta} in the presence of HIV in both human macrophages and microglia. These data suggest that use of addictive substances and dopamine-modulating therapeutics could dysregulate the innate inflammatory response and exacerbate chronic neuroimmunological conditions like HIV. Thus, a detailed understanding of dopamine-mediated changes in inflammation, in particular pathways regulating IL-1{beta}, will be critical to effectively tailor medication regimens.

neuroscience↗

Microglia and macrophages alterations in the CNS during acute SIV infection: a single-cell analysis in rhesus macaques

Human Immunodeficiency Virus (HIV) is widely acknowledged for its profound impact on the immune system. Although HIV primarily affects peripheral CD4 T cells, its influence on the central nervous system (CNS) cannot be overlooked. Within the brain, microglia and CNS-associated macrophages (CAMs) serve as the primary targets for HIV, as well as for the simian immunodeficiency virus (SIV) in nonhuman primates. This infection can lead to neurological effects and the establishment of a viral reservoir. Given the gaps in our understanding of how these cells respond in vivo to acute CNS infection, we conducted single-cell RNA sequencing (scRNA-seq) on myeloid cells from the brains of three rhesus macaques 12-days after SIV infection, along with three uninfected controls. Our analysis revealed six distinct microglial clusters including homeostatic microglia, preactivated microglia, and activated microglia expressing high levels of inflammatory and disease-related molecules. In response to acute SIV infection, the population of homeostatic and preactivated microglia decreased, while the activated and disease-related microglia increased. All microglial clusters exhibited upregulation of MHC class I molecules and interferon-related genes, indicating their crucial roles in defending against SIV during the acute phase. All microglia clusters also upregulated genes linked to cellular senescence. Additionally, we identified two distinct CAM populations: CD14lowCD16hi and CD14hiCD16low CAMs. Interestingly, during acute SIV infection, the dominant CAM population changed to one with an inflammatory phenotype. Notably, specific upregulated genes within one microglia and one macrophage cluster were associated with neurodegenerative pathways, suggesting potential links to neurocognitive disorders. This research sheds light on the intricate interactions between viral infection, innate immune responses, and the CNS, providing valuable insights for future investigations. AUTHOR SUMMARY O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=65 SRC="FIGDIR/small/588047v1_ufig1.gif" ALT="Figure 1"> View larger version (13K): org.highwire.dtl.DTLVardef@1d9fadcorg.highwire.dtl.DTLVardef@1e491daorg.highwire.dtl.DTLVardef@1238f91org.highwire.dtl.DTLVardef@1a6a548_HPS_FORMAT_FIGEXP M_FIG C_FIG HIVs entry into the central nervous system (CNS) can lead to neurological dysfunction, including HIV-associated neurocognitive disorders (HAND), and the establishment of a viral reservoir. While microglia and CNS-associated macrophages (CAMs) are the primary targets of HIV in the CNS, their responses during acute HIV infection remain poorly defined. To address this, we employed the scRNA-seq technique to study microglial and CAM populations in rhesus macaques during acute SIV infection. By identifying signature genes associated with different phenotypes and mapping them to various biological and pathological pathways, we discovered two myeloid cell clusters strongly linked to neurodegenerative disorders. Additionally, other clusters were associated with inflammatory pathways, suggesting varying degrees of activation among different myeloid cell populations in the brain, possibly mediated by distinct signaling pathways. All microglia clusters developed signs of the cellular senescence pathway. These findings shed light on the immunological and pathological effects of different myeloid phenotypes in the brain during acute SIV infection, providing valuable insights for future therapeutic strategies targeting this critical stage and aiming to eliminate the viral reservoir.

microbiology↗